Brink's Files Amended S-4 Detailing NCR Atleos Acquisition, 28% Dilution, and Negative Pro Forma EPS
BCO sits 31% above its 52-week low of $80.1.
Summary
Brink's filed an amended S-4 detailing the financial and regulatory aspects of its acquisition of NCR Atleos, including the issuance of 11.6 million shares (approximately 28% dilution) and a negative pro forma diluted EPS for Q1 2026, despite achieving HSR clearance and projecting $200 million in annual synergies.
Key Events · M&A and Partnerships · BCO
-
Acquisition Details Confirmed
Brink's will acquire NCR Atleos for $30.00 in cash and 0.1574 shares of Brink's Common Stock per NCR Atleos share. The implied value of the consideration has decreased from $50.40 at announcement to $46.49 as of May 21, 2026, due to Brink's stock price decline.
-
Significant Share Dilution
Brink's expects to issue approximately 11.6 million shares of its common stock, which represents a potential dilution of about 28% to existing shareholders.
-
HSR Act Clearance Achieved
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) expired on May 11, 2026, by early termination, removing a key regulatory hurdle for the merger.
-
Updated Financing Structure
The filing details the evolution of the debt financing, including a $2.276 billion draw from a bridge facility and the refinancing of NCR Atleos' $1.468 billion debt through new credit facilities.
Analysis · BCO · Energy & Transportation
This amended S-4 provides critical updates on Brink's acquisition of NCR Atleos, a previously announced transformational deal. The filing confirms the issuance of approximately 11.6 million shares, which represents a substantial dilution of about 28% to existing Brink's shareholders. The unaudited pro forma financials indicate a negative diluted EPS for Q1 2026 and a significant reduction for FY 2025 compared to historical figures, suggesting a notable near-term financial impact from the acquisition and associated debt. While the successful expiration of the HSR Act waiting period on May 11, 2026, is a positive step for deal certainty, and $200 million in annual cost synergies are projected, the immediate financial burden and dilution are significant factors for investors to consider ahead of the shareholder vote.
At the time of this filing, BCO was trading at $104.79 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $80.10 to $136.37. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.